Non acute phase and tendinitis
Conditions
Interventions
Extracorporeal shock wave group:On the basis of conventional rehabilitation treatment, the Swiss SWISS Dolor Clast extracorporeal shock wave therapy device was used. Before treatment, determine the lo
Muscle patch group:On the basis of routine rehabilitation treatment, according to the shape and pain area of the athlete's Achilles tendon, NITREAT Nitto Medical Patch (Beikang, Fuzhou, China) was sel
Sponsors
Tianjin University of Sport
Eligibility
Sex/Gender
All
Age
18 Years to 25 Years
Inclusion criteria
Inclusion criteria: (1) 18-25 years old, college long-distance runner; (2) The course of illness exceeds 2 weeks; (3) Diagnosed with non acute phase tendinitis through clinical examination (such as physical examination, ultrasound examination, etc.); (4) There is dull pain and stiffness in the Achilles tendon, which worsens after activity and improves after rest. The degree of pain is evaluated using the Visual Analog Scale (VAS), with a VAS score between 3-7 points; (5) Normal communication skills, able to cooperate with shock wave and intramuscular plaster therapy; (6) We can provide 100% of the relevant data and information related to this research; (7) Voluntarily participate in this study and sign an informed consent form.
Exclusion criteria
Exclusion criteria: (1) Acute injury: Recent (within 2 weeks) acute injury or exacerbation of Achilles tendon; (2) Merge other foot or ankle joint diseases: exclude diseases that may affect foot and ankle joint function, such as foot fractures (including old fractures), ankle dislocation, ankle instability, gouty arthritis, rheumatoid arthritis, etc; (3) Recent treatment history: Received surgical treatment at the Achilles tendon site, local injection of corticosteroids, and treatment with platelet rich plasma (PRP) within the past 3 months; Received extracorporeal shock wave therapy, muscle patch therapy, or other physical treatments (such as ultrasound, infrared therapy, etc.) for Achilles tendinitis within the past month; (4) Systemic diseases or special physiological conditions: women with serious cardiovascular diseases (such as coronary heart disease, heart failure), uncontrolled diabetes, blood system diseases (such as leukemia, thrombocytopenic purpura), autoimmune diseases (such as systemic lupus erythematosus, ankylosing spondylitis) and other systemic diseases, as well as women in pregnancy or lactation; (5) Subjects with severe mental illness (such as schizophrenia, major depression) or cognitive impairment who are unable to understand the research content, cooperate in completing treatment and evaluation; (6) Allergy history: Allergic to extracorporeal shock waves or muscle patch materials; (7) Psychological factors: the presence of psychological disorders or poor compliance.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Achilles tendon pain score;Achilles tendon function score;Ankle joint function score;Maximum running time;Structural changes of Achilles tendon; | — |
Countries
China
Contacts
Public ContactZheng Wei
Tianjin University of Sport
Outcome results
None listed